Lisa H Lam (Lisa Lam)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 2

Top Topics

Epidermal Growth Factor Receptor

Positive Breast Cancer

Glycemic Control

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Genentech

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Genentech

United States

Clinical Scientist

Publications

Peter Schmid, Nicholas C Turner, Carlos Henrique Barrios, Steven Jay Isakoff, Sung-Bae Kim, Marie-Paule Sablin, Shigehira Saji, Peter Savas, Gregory A Vidal, Mafalda Oliveira, Joyce O'Shaughnessy, Antoine Italiano, Enrique Espinosa, Valentina Boni, Shane White, Beatriz Rojas, Rui Gilberto Ferreira, Yee Soo Chae, Igor Bondarenko, Jieun Lee, Cesar Torres Mattos, Jorge Luis Martinez Rodriguez, Lisa H Lam, Surai Jones, Sarah-Jayne Reilly, Xiayu Huang, Kalpit Shah, Rebecca A Dent
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Solange Peters, Rolf Stahel, Lukas Bubendorf, Philip Bonomi, Augusto Villegas, Dariusz M Kowalski, Christina S Baik, Dolores Isla, Javier De Castro Carpeno, Pilar Garrido Lopez, Achim Rittmeyer, Marcello Tiseo, Christoph Meyenberg, Sanne de Haas, Lisa H Lam, Michael W Lu, Thomas E Stinchcombe
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (1) (2018)